Together on Diabetes

Diabetes is a global epidemic that carries with it a particularly set of complex challenges.Changing lifestyles, low levels of disease awareness and prevention education and poor access to treatment are contributing to the growing prevalence of type 2 diabetes in China and India, the world’s two most populous nations.

Together on Diabetes

Together on Diabetes is the flagship philanthropic program of the Bristol-Myers Squibb Foundation. In China, BMS is working with several foundations to reach out to patients, health care providers and to reduce the socio-economic burden of diabetes management for families and public health facilities. For instance, BMS Foundation is working with the Chinese Center for Disease Control and Prevention on a three-year project to enhance the capacity of rural health care providers to manage and prevent type 2 diabetes at the village level in Western and Central China, where diabetes is growing at a faster rate than in China’s cities. Efforts focus on identifying high-risk rural populations and ensuring timely interventions to prevent disease onset. These interventions include health care provider training, disease screenings and patient education. The Chinese CDC is also mobilizing government and community leaders to prioritize diabetes disease management.

In India, BMS partners with local actors such as the MAMTA Health Institute for Mother and Child to increase the skills of community health volunteers to provide diabetes risk-management education and family counselling for non-communicable diseases. The project is also linking patients to health care providers in order to promote healthy lifestyles, early detection and healthy behaviors.

Partnership objectives:

  • Improve health outcomes of people living with type 2 diabetes in China and India by strengthening patient self-management education, community-based supportive services and broad-based community mobilization.
  • Help communities to build, integrate and coordinate medical, non-medical and policy efforts, and expand the base of community organizations actively involved in and bringing their know-how, reach, influence and assets to the fight against type 2 diabetes.
  • Radically rethink and test new ideas about how diabetes control efforts are approached, designed, implemented and measured given the current and future scale of the epidemic and the long duration of the disease journey.


  • Bristol-Myers Squibb

    Service Providers
    Staff size: 10,000+

    Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail against serious diseases. Around the...

  • Chinese Center for Disease Control and Prevention (China CDC)

    Advocacy NGO
    China | Staff size: Unknown

    Chinese Center for Disease Control and Prevention (China CDC) is a nonprofit institution working in the fields of disease control and prevention, public health management and provision of...

  • Shanghai Charity Foundation

    Implementing NGO
    China | Staff size: 101-250

    Shanghai Charity Foundation is a public non-profit organization approved by Shanghai non-government organization registration authorities. Shanghai Charity Foundation raises funds, organizes...

More Resources

Key Information

LocationEast Asia and Pacific, Viet Nam, Vanuatu, Tuvalu, Tonga, Timor-Leste, Thailand, Solomon Islands, Samoa, Philippines, Papua New Guinea, Palau, Niue, Myanmar, Mongolia, Micronesia, Marshall Islands, Malaysia, Laos, Korea, South, Kiribati, Japan, Indonesia, Fiji, Cook Islands, China, Cambodia
  • Start Date 2012
  • End Date 2017
  • Sectors